It looks like a wave of nanotechnology regulatory frameworks is developing. In mid-October 2010, India announced at a conference that a draft was in the works. From the news item on The Times of India website,
The two-day conference, titled Nanotechnology, materials and composites for frontier applications’, was inaugurated by Chavan at a city hotel. The conference is being hosted by the Bharati Vidyapeeth Deemed University, in association with the North Carolina A&T State University, Greensboro, US, Tuskegee University, Albama, US, and the Centre for Materials for Electronics Technology and the Department of Information Technology, Government of India.
Chavan said, “The nanotechnology field is very exciting, and tremendous impetus will be given for the R&D in this area. A regulatory framework will help in sorting out issues of ethics and copyrights, which are currently being faced by experts in the country.”
He said Rs 1,800 crore have been spent on nano mission and there are close to one thousand researchers working in nanotechnology across the country and a handful of discoveries have been made in the field. “Some potential discoveries from the Indian Institute of Science, Bangalore, Indian Institute of Technology, Delhi and the Advanced Research Centre for Powder Metallurgy and New Materials (ARCI), Hyderabad, have been successful and has been commercialised as well,” Chavan said.
…
“India spends about 1 per cent of gross domestic product on research and development (R&D), which is not very encouraging compared to other countries like the US, which spends 4 to 5 per cent on R&D. We are trying to double it, but at the same time, we would also like to see more participation from the public sector in this area. Of the 1 per cent about 75 to 76 per cent comes from the private sector which is exactly opposite in the western countries. The share of public sector is more there and so should happen in India,” Chavan said.
I find the focus on commercialization and intellectual property unexpected since the discussion on regulatory frameworks in Europe and the US tends to focus on environment, health, and safety issues. For an example about the latest on Europe and nanotechnology and regulatory frameworks, I found this in Tim Haper’s Sept. 29, 2010 posting on his TNTlog,
Plastics & Rubber Weekly reports that the Belgian Environment Minister, Paul Magnette proposed five elements that should be included in nanotechnology legislation, including
* A register of nanomaterials used within the EU is established, so regulators can trace the origin of any nanoparticles to their source if they cause health or environmental problems.
* Manufacturers and retailers inform consumers of the presence of nanomaterials in their products
* Regulations provide for risk evaluation and management of nanomaterials at an EU level
* Member states also draft integrated national strategies for nanotechnology risk management, information dissemination and monitoring
* Claims made on labels of products containing nanomaterials are controlled
What makes the contrast interesting for me is that Harper is the principal for the company, Cientifica (from the About page),
Cientfica is distinct from all other companies providing consulting and information services in its knowledge of both the science and business of emerging technologies. Cientifica employees are from a variety of backgrounds, but all are highly experienced technical project managers and familiar with the commercialization of technology and the transfer of science from the laboratory to the market place.
Cientifica’s numerous reports on commercial aspects of nanotechnology and other emerging technologies are well known for cutting through the hype and getting to the root of the issues. In the same way, Cientifica uses its experience in the reality of commercializing technologies and its wide network of international science and technology practitioners to provide down-to-earth and practical advice to companies, academics and governments.
Cientifica also provides advice to investors who are considering investment in emerging technology companies.
Through this experience Cientifica has a deep understanding of the drivers and associated risks associated with investment and management of cutting edge technology projects.
As you can see the company’s focus is on commercializing emerging technologies, including nanotechnology. By the way, I’m not trying to suggest that Harper doesn’t discuss regulatory frameworks with regard to commercializing nanotechnology. I’m pointing out my own unconscious expectations when the words ‘nanotechnology’, ‘regulatory’, and ‘framework’ are put in the same sentence.